We are live on ! Find out more
BLTE icon

Belite Bio

18 hedge funds and large institutions have $4.51M invested in Belite Bio in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 5

0% more funds holding

Funds holding: 18 → 18 (0)

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

0.22% less ownership

Funds ownership: 0.46% → 0.24% (-0.22%)

74% less capital inflows, than outflows

Capital inflows: $1.7M | Capital outflows: $6.54M

Holders
18
Holders Change
–
Holders Change %
0%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
5
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

BLTE Hedge Fund Activity: Q2 2025 in Review

18 of the 7,634 institutional investors tracked by Wall St. Rank reported a position in Belite Bio (BLTE) for Q2 2025, worth a combined $4.51M — down 55% from $9.9M a quarter earlier.

Fund positioning in BLTE was balanced in Q2 2025: 6 funds opened new positions, 6 closed out, 6 added to existing stakes and 5 trimmed.

The largest buyer was Marshall Wace, opening a new position worth an estimated $579K. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $5.54M sold.

  • 18 institutional investors held Belite Bio (BLTE) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $4.51M of Belite Bio stock for Q2 2025, down 55% quarter-over-quarter.
  • 6 funds opened new Belite Bio positions in Q2 2025 and 6 closed out, a net change of 0 holders.
  • The largest Belite Bio buyer in Q2 2025 was Marshall Wace, an estimated $579K added.
  • The largest Belite Bio seller in Q2 2025 was Alyeska Investment Group, an estimated $5.54M sold.

Based on aggregated 13F filings for Q2 2025.